Search filters

List of works by Satoshi Yoda

A Phase II study of S-1 and irinotecan combination therapy in previously treated patients with advanced non-small cell lung cancer.

scientific article published on 22 January 2015

A phase I study of S-1 and irinotecan combination therapy in previously treated advanced non-small cell lung cancer patients

scientific article

A phase II study of biweekly paclitaxel and carboplatin in elderly patients with advanced non-small cell lung cancer

scientific article published on 7 January 2015

A phase II trial of induction of erlotinib followed by cytotoxic chemotherapy for EGFR mutation-positive non-squamous non-small cell lung cancer patients

scientific article published on 06 September 2019

Activation of the FGF2-FGFR1 autocrine pathway: a novel mechanism of acquired resistance to gefitinib in NSCLC.

scientific article published on 27 March 2013

Bronchoscopic microsampling is a useful complementary diagnostic tool for detecting lung cancer.

scientific article published in April 2011

Claudin-1 is a novel target of miR-375 in non-small-cell lung cancer.

scientific article

Deregulation of histone lysine methyltransferases contributes to oncogenic transformation of human bronchoepithelial cells

scientific article published on 3 November 2008

Distinct epigenetic regulation of tumor suppressor genes in putative cancer stem cells of solid tumors

article

Erlotinib as second- or third-line treatment in elderly patients with advanced non-small cell lung cancer: Keio Lung Oncology Group Study 001 (KLOG001)

scientific article

Expression of fibroblast growth factor 9 is associated with poor prognosis in patients with resected non-small cell lung cancer.

scientific article published on 30 October 2013

FOXD1 expression is associated with poor prognosis in non-small cell lung cancer

scientific article

Impact of EML4-ALK Variant on Resistance Mechanisms and Clinical Outcomes in ALK-Positive Lung Cancer.

scientific article published on 26 January 2018

Landscape of Acquired Resistance to Osimertinib in EGFR-Mutant NSCLC and Clinical Validation of Combined EGFR and RET Inhibition with Osimertinib and BLU-667 for Acquired RET Fusion

scientific article published on 26 September 2018

MET Alterations are a Recurring and Actionable Resistance Mechanism in ALK-Positive Lung Cancer

scientific article published on 21 February 2020

Methylation-induced downregulation of TFPI-2 causes TMPRSS4 overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma

scientific article

Molecular Mechanisms of Resistance to First- and Second-Generation ALK Inhibitors in ALK-Rearranged Lung Cancer

scientific article published on 18 July 2016

Patterns of Metastatic Spread and Mechanisms of Resistance to Crizotinib in ROS1-Positive Non-Small-Cell Lung Cancer

scientific article published on 16 August 2017

RET Solvent Front Mutations Mediate Acquired Resistance to Selective RET Inhibition in RET-Driven Malignancies

scientific article published on 24 January 2020

SHP2 inhibition restores sensitivity in ALK-rearranged non-small-cell lung cancer resistant to ALK inhibitors.

scientific article published on 5 March 2018

Sequential ALK Inhibitors Can Select for Lorlatinib-Resistant Compound ALK Mutations in ALK-Positive Lung Cancer

scientific article published on 12 April 2018

Small cell transformation of ROS1 fusion-positive lung cancer resistant to ROS1 inhibition

scientific article published on 03 August 2020

Targeting oncogenic drivers in lung cancer: Recent progress, current challenges and future opportunities

scientific article published on 16 August 2018

The PCR-invader method (structure-specific 5′ nuclease-based method), a sensitive method for detecting EGFR gene mutations in lung cancer specimens; comparison with direct sequencing ⬇️

scientific article published on February 11, 2011

The combination of multiple receptor tyrosine kinase inhibitor and mammalian target of rapamycin inhibitor overcomes erlotinib resistance in lung cancer cell lines through c-Met inhibition.

scientific article published on 20 July 2010

The new-generation selective ROS1/NTRK inhibitor DS-6051b overcomes crizotinib resistant ROS1-G2032R mutation in preclinical models

scientific article published on 09 August 2019

Tracking the Evolution of Resistance to ALK Tyrosine Kinase Inhibitors through Longitudinal Analysis of Circulating Tumor DNA

scientific article published on 23 January 2018

Unexpected massive hemorrhage following the removal of a pleural drainage tube.

scientific article published on 15 April 2015

Paulina is supported by:

About Paulina

Help